In Depth 2 May 2024
New treatments for cystic fibrosis: boosting life expectancy
Discover how cystic fibrosis treatments are extending life expectancy, with recent advancements set to increase it by 75% by next year.
In Depth
- Latest Posts
In Depth 29 Apr 2024
Can Brazil make cell and gene therapy costs affordable for all?
Found out how Brazil is attempting to make gene and cell therapy costs affordable for all with a new initiative.
In Depth 26 Apr 2024
How to overcome clinical trial challenges
How can companies overcome clinical trial challenges? Sheila Rocchio from eClinical Solutions and Gen Li from Phesi explain.
In Depth 25 Apr 2024
What are biotech companies doing to tackle malaria?
As we observe World Malaria Day on April 25, let’s take a look at some of the latest progress and new treatments against malaria.
In Depth 24 Apr 2024
Overcoming toxicities: are IL-2 smart cytokines the next big thing?
A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it.
In Depth 22 Apr 2024
The biggest private biotech investments in March 2024
The companies Mirador Therapeutics, Alumis, and Sionna Therapeutics bagged the biggest private biotech investments in March 2024.
ADVERTISEMENT
ADVERTISEMENT
In Depth 17 Apr 2024
Small but mighty: The role of small-molecule drugs in disease treatment
Find out more about small-molecule drugs, including how they work and what their advantages and disadvantages are.
In Depth 15 Apr 2024
Does the FDA need to tighten its grip on drug trials in the U.S.?
Studies suggest that the FDA has been less rigorous with its drug approval standards. We looked at the current state of the approval process.
In Depth 10 Apr 2024
Silencing genes to cure diseases: an in-depth look at siRNA
Delve into the promissing and dynamic sector of siRNA technology, with new drug approvals and advancements in delivery methods.
In Depth 8 Apr 2024
A wave of biotech layoffs: will the trend continue throughout 2024?
Thousands of jobs have been at risk over the past year due to mass layoffs by biotech companies across the globe.
In Depth 4 Apr 2024
Seven diseases CRISPR technology could cure
Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool.
In Depth 3 Apr 2024
Hepatitis B: are we edging closer to a cure?
Find out whether we are closing in on a cure for hepatitis B – a virus affecting the liver that can cause acute and chronic disease.
ADVERTISEMENT
